Novartis Ag (NVS) Inventory (2009 - 2026)

Novartis Ag has disclosed Inventory across 18 years of filings, most recently posting $6.2 billion for Q2 2026.

• In Q2 2026, Inventory fell 1.38% year-over-year to $6.2 billion; the TTM figure through Jun 2026 stood at $6.2 billion (down 1.38% YoY), while the FY2025 annual figure was $6.3 billion, up 9.54% from the prior year.
• Inventory came in at $6.2 billion for Q2 2026 at Novartis Ag, down from $6.3 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $8.2 billion in Q2 2023 to a low of $5.6 billion in Q3 2023.
• Average Inventory over 5 years is $6.4 billion, with a median of $6.3 billion recorded in 2025.
• Year-over-year, Inventory increased 19.59% in 2023 and sank 30.15% in 2024.
• Over 5 years, Inventory stood at $7.2 billion in 2022, then slipped by 17.59% to $5.9 billion in 2023, then dropped by 3.21% to $5.7 billion in 2024, then advanced by 9.54% to $6.3 billion in 2025, then slipped by 0.78% to $6.2 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $6.2 billion in Q2 2026, $6.3 billion in Q1 2026, and $6.3 billion in Q4 2025.